Biohacker CRISPRs himself in attempt to get bigger muscles
By GMWatch,
GMWatch
| 12. 11. 2017
A CBS News story reports an attempt by the biohacker Josiah Zayner to genetically modify himself to have bigger muscles, using the CRISPR genome-editing tool.
It seems that Zayner tried to alter his DNA by injecting his forearm with a piece of DNA called a plasmid, containing the gene that codes for the Cas9 genome-editing protein and its guide RNA targeted to the myostatin gene. The myostatin protein encoded by this gene checks the growth of muscles so they don’t become out-of-proportion huge. Zayner’s aim is to disrupt the myostatin gene that blocks muscle growth so that his muscles get larger.
Zayner carried out this process using a CRISPR kit that is available to buy online. Presumably it’s the same one that his own company sells and that he hopes to profit from.
Zayner described to CBS his view of the future possibilities with CRISPR: "Do I wanna be big and muscly? Do I wanna – you know, my muscles have, like, high endurance? Do I want to have dark colour skin or light colour skin or whatever you want...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...